埃克拉 (GS6615) 对心肌张力诱导的前节律电生理学变化的影响
Francisco J Chorro1,2,3, Luis Such-Miquel2,4, Samuel Cuñat5
1Department of Medicine, University of Valencia, Valencia, Spain.
Frontiers in physiology
|February 17, 2025
概括
心肌张力可以导致心律失常. 在实验模型中,晚期的电流抑制剂eleclazine降低了前节律变化,并简化了心室动激活模式.
科学领域:
- 心血管生理学心血管生理学
- 电子生理学 电子生理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 心肌张力被认为是一种前节律不良的因素.
- 在各种模型中,用eleclazine (GS6615) 的晚期电流 (INaL) 抑制已经显示出抗心律失常的潜力.
- 关于在心肌张力过程中对eleclazine的影响的数据有限.
研究的目的:
- 为了研究eleclazine的电生理学影响.
- 为了评估eleclazine在急性心室拉伸期间的疗效.
主要方法:
- 使用了兰登多夫子心脏制剂 (n=26).
- 在基线和eleclazine perfusion期间诱导的左心室拉伸.
- 采用了编程刺激和高分辨率心上表皮图.
主要成果:
- 在基线,心室拉伸降低了折射性和增加了VF主导频率 (DF).
- 电克拉延长了折射性,并降低了DF和传导速度.
- 电克拉防止了拉伸诱导的折射性和DF的变化,并减少了VF复杂性.
结论:
- 埃莱克拉减轻了心肌张力诱导的前节律性电生理变化.
- 埃克拉减缓和简化了心室的激活模式.
- 埃莱克拉证明了作为治疗抗拉伸引起的心律失常的治疗剂的潜力.
相关概念视频
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.2K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.2K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
703
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
703
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
761
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
761
01:12Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
889
Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
889
01:29Electrocardiogram
2.1K
An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
2.1K
01:30Cardiac Action Potential
826
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
826